Literature DB >> 15973150

GABAergic control of hypothalamic melanin-concentrating hormone-containing neurons across the sleep-waking cycle.

Romain Goutagny1, Pierre-Hervé Luppi, Denise Salvert, Damien Gervasoni, Patrice Fort.   

Abstract

The perifornical-lateral hypothalamic area is implicated in regulating waking and paradoxical sleep. The blockade of GABAA receptors by iontophoretic applications of bicuculline (or gabazine) into the perifornical-lateral hypothalamic area induced a continuous quiet waking state associated to a robust muscle tone in head-restrained rats. During the effects, sleep was totally suppressed. In rats killed at the end of a 90 min ejection of bicuculline, Fos expression was induced in approximately 28% of the neurons immunoreactive for hypocretin and in approximately 3% of the neurons immunostained for melanin-concentrating hormone within the ejection site. These results suggest that neurons containing melanin-concentrating hormone are not active during waking and that the lack of a potent GABAergic influence during waking is consistent with their role in sleep regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15973150     DOI: 10.1097/00001756-200507130-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

Review 1.  Brainstem mechanisms of paradoxical (REM) sleep generation.

Authors:  Pierre-Hervé Luppi; Olivier Clement; Emilie Sapin; Christelle Peyron; Damien Gervasoni; Lucienne Léger; Patrice Fort
Journal:  Pflugers Arch       Date:  2011-11-15       Impact factor: 3.657

2.  Regionally selective effects of GABA on hypothalamic GABAA receptor mRNA in vitro.

Authors:  Denys V Volgin; Leszek Kubin
Journal:  Biochem Biophys Res Commun       Date:  2006-12-20       Impact factor: 3.575

3.  The median preoptic nucleus reciprocally modulates activity of arousal-related and sleep-related neurons in the perifornical lateral hypothalamus.

Authors:  Natalia Suntsova; Ruben Guzman-Marin; Sunil Kumar; Md Noor Alam; Ronald Szymusiak; Dennis McGinty
Journal:  J Neurosci       Date:  2007-02-14       Impact factor: 6.167

4.  Disinhibition of perifornical hypothalamic neurones activates noradrenergic neurones and blocks pontine carbachol-induced REM sleep-like episodes in rats.

Authors:  Jackie W Lu; Victor B Fenik; Jennifer L Branconi; Graziella L Mann; Irma Rukhadze; Leszek Kubin
Journal:  J Physiol       Date:  2007-05-10       Impact factor: 5.182

5.  Distribution of hypothalamic neurons with orexin (hypocretin) or melanin concentrating hormone (MCH) immunoreactivity and multisynaptic connections with diaphragm motoneurons.

Authors:  Varun M Badami; Cory D Rice; James H Lois; Jayesh Madrecha; Bill J Yates
Journal:  Brain Res       Date:  2010-02-06       Impact factor: 3.252

6.  GABAergic regulation of the perifornical-lateral hypothalamic neurons during non-rapid eye movement sleep in rats.

Authors:  M N Alam; S Kumar; N Suntsova; T Bashir; R Szymusiak; D McGinty
Journal:  Neuroscience       Date:  2010-02-24       Impact factor: 3.590

7.  Evidence that neurons of the sublaterodorsal tegmental nucleus triggering paradoxical (REM) sleep are glutamatergic.

Authors:  Olivier Clément; Emilie Sapin; Anne Bérod; Patrice Fort; Pierre-Hervé Luppi
Journal:  Sleep       Date:  2011-04-01       Impact factor: 5.849

8.  Optogenetic deconstruction of sleep-wake circuitry in the brain.

Authors:  Antoine Adamantidis; Matthew C Carter; Luis de Lecea
Journal:  Front Mol Neurosci       Date:  2010-01-20       Impact factor: 5.639

9.  Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus.

Authors:  Georg M Stettner; Leszek Kubin
Journal:  J Appl Physiol (1985)       Date:  2012-10-25

10.  A1 receptor mediated adenosinergic regulation of perifornical-lateral hypothalamic area neurons in freely behaving rats.

Authors:  S Rai; S Kumar; M A Alam; R Szymusiak; D McGinty; M N Alam
Journal:  Neuroscience       Date:  2010-01-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.